Company Update (NYSE:PFE): Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1

[Business Wire] – Pfizer Inc. today announced that it will submit a New Drug Application with the United States Food and Drug Administration for palbociclib, combined with letrozole, as first-line systemic treatment of . . . → Read More: Company Update (NYSE:PFE): Pfizer To Submit Palbociclib New Drug Application With FDA Based On Final Results Of PALOMA-1 Similar Articles: Market Update: Pfizer Inc (NYSE:PFE) – AstraZeneca in partnering talks for Alzheimer’s drug Pfizer Inc (NYSE:PFE) – Pfizer Invites Public to Listen to Webcast of April 24 Annual Meeting of Shareholders Market Update (NYSE:PFE): Pfizer Launches 2013 Integrated Annual Review